Harvard Management as of March 31, 2021
Portfolio Holdings for Harvard Management
Harvard Management holds 38 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Royalty Pharma Shs Class A (RPRX) | 26.1 | $467M | 11M | 43.62 | |
| Intercontinental Exchange (ICE) | 12.9 | $230M | 2.1M | 111.68 | |
| Adobe Systems Incorporated (ADBE) | 8.7 | $155M | 326k | 475.37 | |
| Abcellera Biologics (ABCL) | 7.8 | $139M | 4.1M | 33.96 | |
| Facebook Cl A (META) | 6.7 | $121M | 410k | 294.53 | |
| Palo Alto Networks (PANW) | 6.1 | $110M | 341k | 322.06 | |
| Scientific Games (LNW) | 5.8 | $103M | 2.7M | 38.52 | |
| Microsoft Corporation (MSFT) | 3.4 | $62M | 262k | 235.77 | |
| salesforce (CRM) | 1.9 | $35M | 165k | 211.87 | |
| Invesco Qqq Tr Unit Ser 1 (QQQ) | 1.9 | $34M | 108k | 319.13 | |
| Purecycle Technologies (PCT) | 1.8 | $33M | 1.3M | 25.50 | |
| Revolution Medicines (RVMD) | 1.7 | $31M | 670k | 45.88 | |
| Ishares Tr Core S&p500 Etf (IVV) | 1.5 | $26M | 66k | 397.83 | |
| Praxis Precision Medicines I | 1.4 | $26M | 779k | 32.76 | |
| Pliant Therapeutics (PLRX) | 1.2 | $22M | 562k | 39.33 | |
| Relay Therapeutics (RLAY) | 1.0 | $19M | 541k | 34.57 | |
| Unity Software (U) | 1.0 | $19M | 186k | 100.31 | |
| 10x Genomics Cl A Com (TXG) | 0.9 | $16M | 90k | 181.00 | |
| Sana Biotechnology (SANA) | 0.9 | $16M | 469k | 33.47 | |
| Kinnate Biopharma | 0.9 | $16M | 498k | 31.16 | |
| Spdr Gold Tr Gold Shs (GLD) | 0.9 | $16M | 97k | 159.96 | |
| Generation Bio | 0.8 | $15M | 512k | 28.46 | |
| Roblox Corp Cl A (RBLX) | 0.7 | $13M | 198k | 64.83 | |
| Nurix Therapeutics (NRIX) | 0.5 | $9.8M | 315k | 31.09 | |
| Vanguard Tax-managed Intl Ftse Dev Mkt Etf (VEA) | 0.5 | $8.6M | 176k | 49.11 | |
| Pinduoduo Sponsored Ads (PDD) | 0.3 | $5.7M | 43k | 133.89 | |
| Ishares Tr Core S&p Scp Etf (IJR) | 0.3 | $5.5M | 50k | 108.52 | |
| Nucana Sponsored Adr | 0.3 | $5.0M | 992k | 4.99 | |
| Fulcrum Therapeutics (FULC) | 0.3 | $4.8M | 411k | 11.78 | |
| Ishares Tr Core S&p Mcp Etf (IJH) | 0.2 | $4.2M | 16k | 260.28 | |
| Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO) | 0.2 | $4.2M | 81k | 52.05 | |
| Fs Development Corp Ii Com Cl A | 0.2 | $4.0M | 400k | 9.96 | |
| Magenta Therapeutics | 0.2 | $3.9M | 333k | 11.84 | |
| Decibel Therapeutics | 0.2 | $3.7M | 329k | 11.36 | |
| Gemini Therapeutics | 0.2 | $3.4M | 250k | 13.55 | |
| Seres Therapeutics | 0.2 | $2.7M | 132k | 20.59 | |
| Dyne Therapeutics (DYN) | 0.1 | $1.7M | 107k | 15.53 | |
| Dada Nexus Ads | 0.1 | $1.4M | 50k | 27.14 |
